Last week @fda sends out clarification on who can and cannot compound #glp1 like #tirzeaptide and #semaglutide and this week ProRx 503b shuts down GLP 1 compounding while @martymakary is photographed holding bootleg # PEPTIDES: THE 2026 FDA CRACKDOWN CONTROVERSYWhy this is MASSIVE SEO RIGHT NOW BPC 157 banned FDA mulls compounding for peptides previously flagged over safety risks BioSpace FDA Proposes to Exclude GLP 1s From 503B Bulk List Drug Topics FDA Removes 12 Peptides from 503A Category 2 Newtropin FDA Reclassifies BPC 157 & TB 500 What the Research Shows #Shorts YouTube